Kaposi's sarcoma screening: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Kaposi's sarcoma}} | {{Kaposi's sarcoma}} | ||
{{CMG}} {{AE}} {{HL}}{{ADS}} | {{CMG}} {{AE}} {{HL}}{{ADS}} {{Hudakarman}} | ||
==Overview== | ==Overview== |
Revision as of 13:53, 10 October 2019
Kaposi's sarcoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kaposi's sarcoma screening On the Web |
American Roentgen Ray Society Images of Kaposi's sarcoma screening |
Risk calculators and risk factors for Kaposi's sarcoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]Amandeep Singh M.D.[3] Huda A. Karman, M.D.
Overview
According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Kaposi's sarcoma.
Screening
- According to the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Kaposi's sarcoma.